NASDAQ:GDRX GoodRx Q3 2026 Earnings Date & Estimates $3.51 -0.14 (-3.84%) Closing price 11/12/2026 04:00 PM EasternExtended Trading$3.51 0.00 (-0.03%) As of 11/12/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. GoodRx is estimated to report Q3 2026 earnings on Friday, November 13, 2026, after market closes. The conference call is scheduled for November 18, 2026 at 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 13, 2026TimeAfter Market ClosesConference Call DateNovember 18, 2026Conference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from GoodRx in Q3 2026GoodRx is expected to post earnings of $0.0779 per share on revenue of $202.07 million. In the same quarter a year earlier GoodRx reported $0.08 per share on revenue of $196.03 million. GoodRx last reported on August 5, 2026, posting $0.08 per share and beating the $0.0797 consensus estimate. GoodRx has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0779Expected Revenue$202.07 millionPrior-Year EPS$0.08Prior-Year Revenue$196.03 millionExpected EPS Growth-2.7%Expected Revenue Growth+3.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.08 (Beat by +$0.0003)Last Quarter Revenue$200.41 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report GoodRx Q3 2026 Earnings FAQ When does GoodRx report Q3 2026 earnings? GoodRx (NASDAQ:GDRX) is estimated to report Q3 2026 earnings on Friday, November 13, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is GoodRx's Q3 2026 earnings call? GoodRx's Q3 2026 earnings conference call is scheduled for Wednesday, November 18, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for GoodRx? Analysts expect GoodRx to post earnings of $0.0779 per share for Q3 2026. How much revenue is GoodRx expected to report? The consensus revenue estimate for GoodRx is $202.07 million for Q3 2026. GoodRx Earnings HeadlinesFinancial Contrast: GoodRx (GDRX) & Its RivalsNovember 12 at 2:46 AM | americanbankingnews.comGoodRx stock rises on Google Cloud healthcare AI partnershipNovember 10 at 6:35 PM | finance.yahoo.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 13 at 1:00 AM | Profits Run (Ad)GoodRx Brings Prescription Pricing Intelligence to Google Cloud’s Gemini for HealthcareNovember 10 at 8:34 AM | finance.yahoo.comGoodRx Brings Prescription Pricing Intelligence to Google Cloud's Gemini for HealthcareNovember 10 at 8:05 AM | businesswire.comGoodRx Holdings Delays Third-Quarter Report Filing Amid Restatement WorkNovember 10 at 7:31 AM | tipranks.comSee More GoodRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email. Email Address About GoodRxGoodRx (NASDAQ:GDRX) operates a digital healthcare platform that helps consumers in the United States compare prescription medication prices at pharmacies. Its website and mobile app provide free price comparisons and discounts that consumers can use when paying for eligible prescriptions. The company also offers subscription services, including GoodRx Gold, and provides access to telehealth and other care services through GoodRx Care. Its platform connects consumers with pharmacies and healthcare providers, while its services for pharmaceutical companies include programs that help make medications and savings offers available to patients. Founded in 2011, GoodRx is based in Santa Monica, California. The company’s business focuses on the U.S. healthcare market.View GoodRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
